ASH 2024 highlights lymphoma

CE / CME

CCO’s Conference to Clinic Highlights ​From ASH 2024 Annual Meeting: Lymphomas

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: February 13, 2025

Expiration: August 12, 2025

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following is true of first-line treatment with acalabrutinib (A) + venetoclax (V) ± obinutuzumab (O) vs chemoimmunotherapy (CIT) in the phase III AMPLIFY trial in patients with CLL, as presented at ASH 2024?

2.

Which of the following therapies given in combination with lenalidomide/rituximab demonstrated improved PFS with a manageable safety profile for patients with R/R FL in the phase III inMIND trial and may represent a potential new standard of care?